Lesaka Technologies, Inc.
NASDAQ:LSAKSoftware - Infrastructure
-$0.03 today
- Market cap
- $281.25M
- Beta
- 0.32
- P/E (TTM)
- -12.0
- EPS (TTM)
- -$0.38
Volume 0.18M
Average 0.13M
LSAK Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Lesaka Technologies, Inc.NASDAQ: LSAK
Research & Development · Q3 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 0 | — |
| FY2024 | 2024-06-30 | 0 | -100.0% |
| FY2023 | 2023-06-30 | 500K | +0.0% |
| FY2022 | 2022-06-30 | 500K | +66.7% |
| FY2021 | 2021-06-30 | 300K | — |
Research & Development vs competitors
How LSAK compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -100.0% is the lowest of 4, against a peer median of +6.3%.
- Research & development amounts to 0.0% of revenue for LSAK, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $62.87M USD | +6.3% | +14.3% | 4.4% | |
NYAXNayax Ltd. | LTM Mar 2026 | $30.99M USD | +6.5% | +13.6% | 7.2% |
| LTM Mar 2026 | $13K USD | -99.8% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | R$0 BRL | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding LSAK) | — | +6.3% | +13.9% | 0.0% | |
Competitors are the stored peer set for LSAK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 130.79M | 222.61M | 527.97M | 564.22M | 659.7M |
| Cost of Revenue | 96.25M | 168.32M | 417.54M | 442.67M | 486.55M |
| Gross Profit | 34.54M | 54.29M | 110.43M | 121.55M | 173.16M |
| Gross Margin | 26.4% | 24.4% | 20.9% | 21.5% | 26.2% |
| Research & Development | 300K | 500K | 500K | 0 | 0 |
| Selling, General & Admin | 84.06M | 0 | 0 | 91.97M | 131.51M |
| Operating Expenses | 88.41M | 94.49M | 125.77M | 117.96M | 200.26M |
| Depreciation & Amortization | 4.35M | 7.58M | 23.69M | 23.67M | 33.72M |
| EBITDA | (23.17M) | (20.7M) | 15.38M | 29.8M | (50.77M) |
| EBITDA Margin | -17.7% | -9.3% | 2.9% | 5.3% | -7.7% |
| Operating Income | (53.87M) | (40.2M) | (15.35M) | 3.59M | (27.1M) |
| Operating Margin | -41.2% | -18.1% | -2.9% | 0.6% | -4.1% |
| Interest Income | 2.42M | 2.09M | 1.85M | 2.29M | 2.6M |
| Interest Expense | 2.98M | 5.83M | 18.57M | 18.93M | 21.45M |
| Other Income / Expenses | 23.38M | (3.35M) | (22.04M) | (17.67M) | (78.73M) |
| Income Before Tax | (30.5M) | (43.55M) | (37.38M) | (14.08M) | (105.83M) |
| Pre-Tax Margin | -23.3% | -19.6% | -7.1% | -2.5% | -16.0% |
| Income Tax Expense | 7.56M | 327K | (2.31M) | 3.36M | (18.2M) |
| Net Income | (38.06M) | (43.88M) | (35.07M) | (17.44M) | (87.5M) |
| Net Margin | -29.1% | -19.7% | -6.6% | -3.1% | -13.3% |
| EPS (Basic) | (0.67) | (0.75) | (0.56) | (0.27) | (1.14) |
| EPS (Diluted) | (0.67) | (0.75) | (0.56) | (0.27) | (1.14) |
| Weighted Avg Shares | 56.33M | 57.21M | 63.13M | 61.28M | 76.76M |
| Weighted Avg Shares (Diluted) | 56.33M | 57.21M | 63.13M | 61.28M | 76.76M |
Lesaka Technologies, Inc.
NASDAQ:LSAK
Intrinsic Alpha fair value
Locked
Current Price
$3.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.